Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGM | P11217 | 3/20 | 0.48 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.43 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.43 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.43 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.43 |
| ▸ | TK2 | O00142 | 2/20 | 0.43 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.43 |
| ▸ | CDK1 | P06493 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | MTOR | P42345 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.39 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.39 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20534354 | 1.00 | PYGM (0.48) | PYGMSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL21570800 | 0.88 | PYGM (0.46) | PYGMSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL27760732 | 0.86 | PYGM (0.51) | PYGMSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL28344680 | 0.85 | PYGM (0.50) | PYGMSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL27618439 | 0.85 | PYGM (0.46) | PYGMSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL1067013 | 0.85 | PYGM (0.52) | PYGMSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL21458099 | 0.85 | PYGM (0.52) | PYGMSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL29002253 | 0.83 | PYGM (0.46) | PYGMSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL5145484 | 0.82 | PYGM (0.49) | PYGMSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL27965304 | 0.82 | PYGM (0.49) | PYGMSLC28A1SLC28A2SLC29A1SLC28A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 216 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118161602-A | RNA for treating autoimmune diseases | 生物技术公司 | 2024-06-11 | — | — | CN | claimed |
| CN-113396219-B | Purification of mRNA by tangential flow filtration | ETHRIS GMBH (DE) | 2026-05-26 | — | — | CN | disclosed |
| CN-122070366-A | Cyclic RNA compositions and methods | 欧纳医疗公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-122029278-A | Constructs, methods and uses for the preparation of circular RNAs | 上海环码生物医药有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-120202302-A | CTLA4 bi-allelic knockout | 埃门多生物公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-120158444-A | Negative selection method and system for purifying circular nucleic acid | 上海环码生物医药有限公司 | 2025-06-17 | — | — | CN | disclosed |
| CN-120153078-A | RNA molecules encoding RSV-F and vaccines containing the same | 辉瑞大药厂 | 2025-06-13 | — | — | CN | disclosed |
| CN-120153081-A | APLP2 safe harbor site knock-in strategy | 埃门多生物公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-120129532-A | Stabilized lipid or lipid nanoparticle suspensions | 埃泽瑞斯公司 | 2025-06-10 | — | — | CN | disclosed |
| CN-120129688-A | Efficient method for preparing highly purified 5' -capped oligonucleotides | 垂林克生物技术有限公司 | 2025-06-10 | — | — | CN | disclosed |
| EP-1092038-A4 | OCT1p, A PROTEIN HAVING HOMOLOGY TO THE ORGANIC AND SUGAR TRANSPORTER FAMILY OF PROTEINS, AND USES THEREOF | MILLENNIUM PHARM INC (US) | 2003-04-02 | — | — | EP | disclosed |
| US-20030027999-A1 | Nucleotide sequences coding polypeptide for use in the treatment of muscula, immunological, cancer, autoimmune and respiratory disorders | HUMAN GENOME SCIENCES, INC. | 2003-02-06 | — | — | US | disclosed |
| WO-2001079467-A2 | IDENTIFICATION OF A RENAL NADPH OXIDASE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY OF THE DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 2001-10-25 | — | — | WO | disclosed |
| EP-1092038-A1 | OCT1p, A PROTEIN HAVING HOMOLOGY TO THE ORGANIC AND SUGAR TRANSPORTER FAMILY OF PROTEINS, AND USES THEREOF | Millennium Pharmaceuticals, Inc. (US) | 2001-04-18 | — | — | EP | disclosed |
| WO-1999067415-A9 | NOVEL MOLECULES OF THE T110-RELATED PROTEIN FAMILY AND USES THEREOF | MILLENNIUM BIOTHERAPEUTICS INC (US) | 2000-06-29 | — | — | WO | disclosed |
| WO-2000000633-A1 | OCT1p, A PROTEIN HAVING HOMOLOGY TO THE ORGANIC AND SUGAR TRANSPORTER FAMILY OF PROTEINS, AND USES THEREOF | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2000-01-06 | — | — | WO | disclosed |
| EP-0506892-B1 | BORONATED NUCLEOSIDES | BORON BIOLOG INC (US) | 1997-10-08 | — | — | EP | disclosed |
| EP-0649411-A4 | BORONATED COMPOUNDS. | BORON BIOLOG INC (US) | 1995-07-12 | — | — | EP | disclosed |
| EP-0649411-A1 | BORONATED COMPOUNDS | BORON BIOLOGICALS, INC. (US) | 1995-04-26 | — | — | EP | disclosed |
| US-5130302-A | Antiinflammatory agents or antitumor agents | BORON BILOGICALS, INC. (US) | 1992-07-14 | — | — | US | disclosed |